The latest closing stock price for EYEPOINT PHARMACEUTICALS, INC as of January 21, 2025 is 7.63.
An investor who bought $1,000 worth of EYEPOINT PHARMACEUTICALS, INC stock at the IPO in 2018 would have $-337 today, roughly 0 times their original investment - a -5.69% compound annual growth rate over 7 years.
The all-time high EYEPOINT PHARMACEUTICALS, INC stock closing price was 37.70 on October 03, 2018.
The EYEPOINT PHARMACEUTICALS, INC 52-week high stock price is 30.99, which is 306.2% above the current share price.
The EYEPOINT PHARMACEUTICALS, INC 52-week low stock price is 6.90, which is 9.6% below the current share price.
The average EYEPOINT PHARMACEUTICALS, INC stock price for the last 52 weeks is 13.31.
An investor who bought $1,000 worth of EYEPOINT PHARMACEUTICALS, INC stock at the IPO in 2018 would have $-337 today, roughly 0 times their original investment - a -5.69% compound annual growth rate over 7 years.
The all-time high EYEPOINT PHARMACEUTICALS, INC stock closing price was 37.70 on October 03, 2018.
The EYEPOINT PHARMACEUTICALS, INC 52-week high stock price is 30.99, which is 306.2% above the current share price.
The EYEPOINT PHARMACEUTICALS, INC 52-week low stock price is 6.90, which is 9.6% below the current share price.
The average EYEPOINT PHARMACEUTICALS, INC stock price for the last 52 weeks is 13.31.